Ezoulin MJ et al. |
Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment. |
2006 |
Toxicol In Vitro |
pmid:16472967
|
Isobe J and Mizuno A |
Aspects of PAF (platelet activating factor)-induced aggregation by using rabbit platelets. |
1982 |
Tokushima J. Exp. Med. |
pmid:7170716
|
Inoue Y et al. |
Effect of a platelet activating factor antagonist and antithrombin III on septicemia and endotoxemia in rats. |
1991 |
Tohoku J. Exp. Med. |
pmid:2063402
|
Nishihira J et al. |
Purification and characterization of the specific binding protein for platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from human platelets. |
1985 |
Tohoku J. Exp. Med. |
pmid:3001971
|
Le Blanc K et al. |
Impaired platelet binding of fibrinogen due to a lower number of GPIIB/IIIA receptors in polycythemia vera. |
1998 |
Thromb. Res. |
pmid:9772010
|
Eche N et al. |
Platelet aggregating and procoagulant activities of cultured human breast cancer cells (FAM). |
1986 |
Thromb. Res. |
pmid:3726808
|
Powling MJ and Hardisty RM |
Differential effects of 12-O-tetradecanoylphorbol 13-acetate on platelet responses to various agonists in the presence and absence of extracellular Ca2+. |
1986 |
Thromb. Res. |
pmid:3787566
|
Siffert W et al. |
Inhibition of platelet aggregation by amiloride. |
1986 |
Thromb. Res. |
pmid:3787567
|
Alam I et al. |
Human and rabbit platelets form platelet-activating factor in response to calcium ionophore. |
1983 |
Thromb. Res. |
pmid:6407140
|
Belch JJ et al. |
Whole blood white cell aggregation: a novel technique. |
1987 |
Thromb. Res. |
pmid:2448894
|
Ostermann G et al. |
Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor. |
1983 |
Thromb. Res. |
pmid:6408754
|
Nguyên P et al. |
Mechanisms of the platelet aggregation induced by activated neutrophils and inhibitory effect of specific PAF receptor antagonists. |
1995 |
Thromb. Res. |
pmid:7778064
|
Namm DH and High JA |
Thrombin-induced formation of a polar lipid material within platelets that possesses platelet-activating activity. |
1980 |
Thromb. Res. |
pmid:7209881
|
Hanss M and Dechavanne M |
48740 RP, an antagonist of PAF, does not affect human plasma fibrinolysis before and after venous occlusion. |
1988 |
Thromb. Res. |
pmid:3126559
|
Okamoto M et al. |
Platelet activating factor (PAF) involvement in endotoxin-induced thrombocytopenia in rabbits: studies with FR-900452, a specific inhibitor of PAF. |
1986 |
Thromb. Res. |
pmid:3754990
|
Violi F et al. |
Inhibition of cyclooxygenase-independent platelet aggregation by sodium salicylate. |
1989 |
Thromb. Res. |
pmid:2506658
|
Shukla SD et al. |
Hypersensitivity of diabetic human platelets to platelet activating factor. |
1992 |
Thromb. Res. |
pmid:1329254
|
Tsien WH et al. |
Variable responses of human platelets to synthetic platelet activating factor and their modification by epinephrine. |
1982 |
Thromb. Res. |
pmid:7164038
|
Westwick J et al. |
Comparison of the effects of low molecular weight heparin and unfractionated heparin on activation of human platelets in vitro. |
1986 |
Thromb. Res. |
pmid:3715810
|
Valone FH |
Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers. |
1987 |
Thromb. Res. |
pmid:3590086
|
Tokumura A et al. |
Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists. |
1987 |
Thromb. Res. |
pmid:3590110
|
Kloprogge E et al. |
Properties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered human platelets. |
1983 |
Thromb. Res. |
pmid:6222507
|
Wade PJ et al. |
Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets. |
1986 |
Thromb. Res. |
pmid:3961730
|
Karlsson H et al. |
Heparin ameliorates pulmonary hypertension induced by platelet-activating factor in pigs. |
1998 |
Thromb. Res. |
pmid:9694244
|
Cox CP and Wood KL |
Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam. |
1987 |
Thromb. Res. |
pmid:3629553
|
Catalán RE et al. |
Dissociation between secretion and protein phosphorylation in agonist-stimulated platelets; action of PCA-4230, a new antithrombotic drug. |
1994 |
Thromb. Res. |
pmid:7974386
|
Ostermann G et al. |
Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor. |
1987 |
Thromb. Res. |
pmid:3629555
|
Nishizawa EE and Della-Coletta AA |
The formation of a thrombin-like material (TLM) following stimulation of leukocytes. |
1984 |
Thromb. Res. |
pmid:6484896
|
Valone FH |
Platelet-activating factor binding and metabolism during human platelet aggregation. |
1988 |
Thromb. Res. |
pmid:3400077
|
Ostermann G et al. |
Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets. |
1984 |
Thromb. Res. |
pmid:6710440
|
Petty AC and Scrutton MC |
Platelet aggregation in whole blood: is the response to adrenaline, 5-hydroxytryptamine and PAF a direct consequence of stimulation by these agonists? |
1989 |
Thromb. Res. |
pmid:2749609
|
Lalau Keraly C et al. |
Inhibition by ticlopidine of Paf-acether-induced in vitro aggregation of rabbit and human platelets. |
1984 |
Thromb. Res. |
pmid:6740569
|
Violi F et al. |
Human platelet aggregation by PAF and thromboxane production. |
1987 |
Thromb. Res. |
pmid:3424290
|
Bernat A and Herbert JM |
Effect of various drugs on adriamycin-enhanced venous thrombosis in the rat: importance of PAF. |
1994 |
Thromb. Res. |
pmid:8073411
|
Pletscher A et al. |
LDL induced shape change reaction of platelets is not due to PAF. |
1989 |
Thromb. Res. |
pmid:2609294
|
Cox CP |
Effects of CV-3988, an antagonist of platelet-activating factor (PAF), on washed rabbit platelets. |
1986 |
Thromb. Res. |
pmid:2421432
|
Croft KD and Beilin LJ |
Platelet and neutrophil function and eicosanoid release in a subject with abetalipoproteinaemia. |
1993 |
Thromb. Res. |
pmid:8385810
|
Kohayakawa M and Inoue K |
Augmentation of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF)-induced human platelet activation by C-reactive protein. |
1986 |
Thromb. Res. |
pmid:3083530
|
Ostermann G et al. |
The role of lipoproteins in the degradation of platelet-activating factor. |
1986 |
Thromb. Res. |
pmid:3798402
|
Ostermann G et al. |
Inhibition of PAF-induced human platelet responses by newly synthesized ether phospholipids. |
1991 |
Thromb. Res. |
pmid:2028445
|
Joseph R et al. |
Endothelin-1 and human platelet activity. |
1991 |
Thromb. Res. |
pmid:2028454
|
Suzuki K et al. |
The influence of 2-mercaptoethanol on von Willebrand factor and bovine platelet aggregating factor. |
1980 Feb 1-15 |
Thromb. Res. |
pmid:6966083
|
Küster LJ and Frölich JC |
PAF-induced platelet aggregation and TXB2 formation. |
1989 |
Thromb. Res. |
pmid:2922704
|
Ishii H et al. |
A platelet aggregating substance contained in xanthine oxidase preparation from cow's milk. |
1982 |
Thromb. Res. |
pmid:6897588
|
Ostermann G et al. |
The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients. |
1988 |
Thromb. Res. |
pmid:3232123
|
Neiman J et al. |
Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal. |
1989 |
Thromb. Res. |
pmid:2617478
|
Avdonin PV et al. |
Evidence for the receptor-operated calcium channels in human platelet plasma membrane. |
1987 |
Thromb. Res. |
pmid:2438805
|
Csáki C et al. |
Role of platelet-activating factor in the development of endothelial dysfunction in hemorrhagic hypotension and retransfusion. |
1992 |
Thromb. Res. |
pmid:1412179
|
May JA et al. |
Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man. |
1997 |
Thromb. Res. |
pmid:9361371
|
Lian EC et al. |
Purification and some properties of a protein obtained from normal human plasma which inhibits the platelet aggregation induced by thrombotic thrombocytopenic purpura plasma. |
1984 |
Thromb. Res. |
pmid:6420930
|